With the overlap of flu season and the novel coronavirus (SARS-CoV-2) outbreak, it is vital that clinical and public health laboratories have access to a single test that can detect RNA from multiple respiratory viruses. Thermo Fisher Scientific has worked rapidly to develop a new multiplex real-time PCR diagnostic kit for detecting and differentiating SARS-CoV-2, influenza A, and influenza B.

Request a quote